Benjamin Oshlaci

Title: The Innovations of Benjamin Oshlaci

Introduction

Benjamin Oshlaci is an accomplished inventor based in New York, NY (US). He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of oral methylphenidate formulations. His innovative approach aims to enhance the effectiveness of medication while minimizing side effects.

Latest Patents

Oshlaci holds a patent for "Controlled/modified release oral methylphenidate formulations." This invention is directed towards oral modified and controlled release methylphenidate formulations that provide a rapid initial onset of effect and a prolonged duration of effect. The formulation is designed to ensure that the peak concentration is lower than that of the reference standard for immediate release methylphenidate formulations. Additionally, it aims to prevent any adverse effects on the patient's appetite during dinner and their sleep thereafter.

Career Highlights

Benjamin Oshlaci has made notable strides in his career, particularly through his work at Euro-Celtique S.A. His expertise in pharmaceutical formulations has positioned him as a key player in the industry. With a focus on improving patient outcomes, he continues to explore innovative solutions in medication delivery.

Collaborations

Oshlaci has collaborated with esteemed colleagues such as Paul D. Goldenheim and Richard S. Sackler. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

In summary, Benjamin Oshlaci is a pioneering inventor whose work in controlled release methylphenidate formulations has the potential to significantly improve patient care. His dedication to innovation in the pharmaceutical field continues to inspire advancements in medication delivery systems.